Omdia is part of Informa TechTarget

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world’s technology buyers and sellers. All copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.’s registered office is 275 Grove St. Newton, MA 02466.

Josh Builta

Senior Director, Enterprise Platforms & Applications

As the senior research director for Enterprise Platforms & Applications at Omdia, Josh Builta leads a talented team of analysts producing valuable insights on artificial intelligence (AI), Internet of Things (IoT), digital workplace, and other enterprise technology markets. In this role, Josh manages the day-to-day operations of these teams and guides their strategic development to ensure they produce a compelling research portfolio that meets the demands of Omdia’s global client base. Using an extensive network of industry contacts, Josh regularly contributes to market intelligence reports and frequently leads consulting projects for high-profile clients. His expertise spans a broad technology spectrum, from hardware components to connectivity technologies and vertical market use cases.

Before Omdia, Josh served as the vice president of product management at Ingenu, formulating the company’s product roadmap and guiding cross-functional teams. From 2010 to 2016, he led IHS Markit’s coverage of the IoT market and guided the launch of the first syndicated intelligence service. Josh’s experience also includes analyst roles with the Department of Defense and Department of Homeland Security, where he directly advised senior government and military officials on national security matters.

Follow Analyst
Latest View All
UsernamePublicRestriction

Register

Josh Builta

Email Author

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.